Celgene competitors
Celgene Competitors include Regeneron Pharmaceuticals, Sanofi, Gilead Sciences, Amgen and Shire.
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. |  Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. |  Amgen Amgen engages in the development of human therapeutic products in supportive of cancer care, inflammation, nephrology and bone diseases. | |||
Founding Date | Founding Date 1986 | Founding Date 1988 | Founding Date 2004 | Founding Date 1987 | Founding Date 1980 | Founding Date 1986 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||
Locations | Locations Summit, US HQ Singapore, SG Boudry, CH | Locations Tarrytown, US HQ Dublin, IE Limerick, IE Greater London, GB Rensselaer, US Bernards, US | Locations Paris, FR HQ Macquarie Park, AU Ontario, CA Beijing, CN Hong Kong, HK New Delhi, IN Tokyo, JP see more | Locations Foster City, US HQ Seattle, US San Dimas, US Oceanside, US Fremont, US Branford, US | Locations Thousand Oaks, US HQ Sydney, AU North Ryde, AU Vienna, AT Brussels, BE São Paulo, BR Mississauga, CA see more | Locations Dublin, IE HQ Buenos Aires, AR Sydney, AU Wien, AT Bruxelles, BE Chácara Santo Antonio (Zona Sul), BR Sofia, BG see more |
Employees | Employees 7,467 | Employees 6,5706% increase | Employees 106,566 | Employees 10,00011% increase | Employees 20,800 | Employees 23,044 |
Valuation ($) | Valuation ($) 47.7 b | Valuation ($) 41.3 b | Valuation ($) 118.9 b | Valuation ($) 84.8 b | Valuation ($) 122.4 b | Valuation ($) 53.4 b |
Twitter followers | Twitter followers 19.1 k | Twitter followers 12.6 k | Twitter followers 101.3 k | Twitter followers 27 k | Twitter followers 65.4 k | Twitter followers 6.2 k |
Financial ⚠ | ||||||
Revenue (est.) | Revenue (est.) $13b (FY, 2017) | Revenue (est.) $5.9b (FY, 2017) | Revenue (est.) €37.1b (FY, 2015) | Revenue (est.) $26.1b (FY, 2017) | Revenue (est.) $22.8b (FY, 2017) | Revenue (est.) £52.3m (FY, 2017) |
Cost of goods | Cost of goods $461m (FY, 2017) | Cost of goods $202.5m (FY, 2017) | Cost of goods €10.9b (FY, 2015) | Cost of goods $4.4b (FY, 2017) | Cost of goods $4.1b (FY, 2017) | Cost of goods N/A |
Gross profit | Gross profit $12.5b (FY, 2017) | Gross profit $5.7b (FY, 2017) | Gross profit €26.1b (FY, 2015) | Gross profit $21.7b (FY, 2017) | Gross profit $18.8b (FY, 2017) | Gross profit N/A |
Net income | Net income $2.9b (FY, 2017) | Net income $1.2b (FY, 2017) | Net income €4.4b (FY, 2015) | Net income $4.6b (FY, 2017) | Net income $2b (FY, 2017) | Net income £3.1m (FY, 2017) |
Operating ⚠ | ||||||
Countries | Countries N/A | Countries N/A | Countries N/A | Countries 30 (FY, 2016) | Countries N/A | Countries 100 (FY, 2017) |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 3 (FY, 2016) | Phase I Trials Products N/A | Phase I Trials Products 7 (FY, 2017) |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 12 (FY, 2016) | Phase II Trials Products N/A | Phase II Trials Products 10 (FY, 2017) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 7 (Y, 2016) | Phase III Trials Products 6 (FY, 2016) | Phase III Trials Products N/A | Phase III Trials Products 15 (FY, 2017) |
Projects in R&D Pipeline | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 43 (Y, 2016) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 40 (FY, 2017) |
Funding | ||||||
Total funding raised | Total funding raised N/A | Total funding raised $ 8.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 175.5m | Total funding raised N/A |
For sources of this data, please see the company profileDownload Excel
View company profiles
Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
6,570↑ 6% increase
Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
View companyGilead Sciences
HQ
Foster City, US
Employees
10,000↑ 11% increase
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
View companyAmgen
HQ
Thousand Oaks, US
Employees
20,800
Amgen engages in the development of human therapeutic products in supportive of cancer care, inflammation, nephrology and bone diseases.
View company